NCT02802852View on ClinicalTrials.gov

Proteomics and Stem Cell Therapy as a New Vascularization Strategy

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2019

Conditions
Critical Limb Ischemia
Interventions
DEVICE

Pneumatic calf compression

Application of a pneumatic calf compression device for two hours per day, every day for 30 days.

DRUG

Filgrastim

Administration of Filgrastim 10 mcg/kg every 3rd day for 30 days

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT02802852 - Proteomics and Stem Cell Therapy as a New Vascularization Strategy | Biotech Hunter | Biotech Hunter